Tamoxifen (Nolvadex) | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Tamoxifen (Nolvadex)
Canada

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

Contact Supplier

Topscience Biotech specializes in R&D, production, sales of Sodium Hyaluronate, focusing on Cosmetics, Medical, Pharmaceutical Grade HA

Contact Supplier

Alchem offers Phytochemical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

Contact Supplier

AMI Lifesciences is Driven by Chemistry. Powered by People.

Contact Supplier

China

Contact Supplier

Tamoxifen (Nolvadex)

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 12 USDMF, 6 CEP/COS, 4 JDMF, 4 KDMF, 13 NDC API, 20 Listed Suppliers, $ API Reference Price

41 API Suppliers
12 USDMF
6 CEP/COS
4 JDMF
4 KDMF
13 NDC API
20 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

13 Drugs in Development

13 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

129 FDF Dossiers, 26 FDA Orange Book, 54 Europe, 6 Canada, 14 Australia, 9 South Africa, 20 Listed Dossiers

129 FDF Dossiers
26 FDA Orange Book
54 Europe
6 Canada
14 Australia
9 South Africa
20 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;ORAL - EQ 20MG BASE/10ML

TABLET;ORAL - EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
SOLUTION;ORAL - EQ 20MG BASE/10ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 3 Rochem International Inc, 18 SPI Pharma, 7 DKSH, 7 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 5 Actylis, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 24 BASF, 1 Bioplus Life Sciences, 1 Clariant, 10 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 7 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 37 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 28 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 3 Silverline Chemicals, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 3 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

88 Fillers, Diluents & Binders, 51 Coating Systems & Additives, 32 Direct Compression, 29 Thickeners and Stabilizers, 27 Controlled & Modified Release, 26 Granulation, 25 Disintegrants & Superdisintegrants, 22 Taste Masking, 20 Film Formers & Plasticizers, 18 Solubilizers, 17 Co-Processed Excipients, 17 Chewable & Orodispersible Aids, 15 Parenteral, 14 Topical, 13 Lubricants & Glidants, 10 Rheology Modifiers, 5 Empty Capsules, 5 API Stability Enhancers, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 Coloring Agents, 2 Surfactant & Foaming Agents, 1 Soft Gelatin

88 Fillers, Diluents & Binders
51 Coating Systems & Additives
32 Direct Compression
29 Thickeners and Stabilizers
27 Controlled & Modified Release
26 Granulation
25 Disintegrants & Superdisintegrants
22 Taste Masking
20 Film Formers & Plasticizers
18 Solubilizers
17 Co-Processed Excipients
17 Chewable & Orodispersible Aids
15 Parenteral
14 Topical
13 Lubricants & Glidants
10 Rheology Modifiers
5 Empty Capsules
5 API Stability Enhancers
5 Emulsifying Agents
4 Vegetarian Capsules
4 Coloring Agents
2 Surfactant & Foaming Agents
1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 24 News #PharmaBuzz

1 Data Compilation #PharmaFlow
24 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 53 Regulatory FDF Prices

2 US Medicaid Prescriptions
53 Regulatory FDF Prices

MARKET PLACE

6 APIs, 9 FDF Dossiers

6 APIs
9 FDF Dossiers

REF. STANDARDS & IMPURITIES

3 EDQM

3 EDQM

$ API Ref.Price (USD/KG) : 333 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 2APOTEX INC

02 2Pharmascience Inc.

03 2TEVA CANADA LIMITED

filter Active Ingredients Reset all filters

6 All

01 4TAMOXIFEN (TAMOXIFEN CITRATE)

02 2Tamoxifen Citrate

filter Dosage Form Reset all filters

6 All

01 6TABLET

filter Brand Name Reset all filters

6 All

01 1APO-TAMOX TAB 10MG

02 1APO-TAMOX TAB 20MG

03 2PMS-TAMOXIFEN

04 2TEVA-TAMOXIFEN

List of Suppliers

Product Main Page

01

APOTEX INC

IMCAS Asia

Not Confirmed

APOTEX INC

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

TAMOXIFEN (TAMOXIFEN CITRATE)

Brand Name : APO-TAMOX TAB 20MG

Dosage Form : TABLET

Dosage Strength : 20MG

Packaging : 30/100/250

Approval Date :

Application Number : 812390

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

APOTEX INC

IMCAS Asia

Not Confirmed

APOTEX INC

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

TAMOXIFEN (TAMOXIFEN CITRATE)

Brand Name : APO-TAMOX TAB 10MG

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 60/100/500

Approval Date :

Application Number : 812404

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Pharmascience Inc.

IMCAS Asia

Not Confirmed

Pharmascience Inc.

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Tamoxifen Citrate

Brand Name : PMS-TAMOXIFEN

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 250

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

04

Pharmascience Inc.

IMCAS Asia

Not Confirmed

Pharmascience Inc.

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Tamoxifen Citrate

Brand Name : PMS-TAMOXIFEN

Dosage Form : TABLET

Dosage Strength : 20MG

Packaging : 250

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

05

TEVA CANADA LIMITED

IMCAS Asia

Not Confirmed

TEVA CANADA LIMITED

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

TAMOXIFEN (TAMOXIFEN CITRATE)

Brand Name : TEVA-TAMOXIFEN

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 60/100/250TAB

Approval Date :

Application Number : 851965

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

TEVA CANADA LIMITED

IMCAS Asia

Not Confirmed

TEVA CANADA LIMITED

IMCAS Asia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

TAMOXIFEN (TAMOXIFEN CITRATE)

Brand Name : TEVA-TAMOXIFEN

Dosage Form : TABLET

Dosage Strength : 20MG

Packaging : 30/100TAB

Approval Date :

Application Number : 851973

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!